Tyme Technologies Inc
TYME
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-6,388,570.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.13 |
| Beta | 0.92 |
| Outstanding Shares | 172,206,894 |
Return
| Return on Equity | -32.34% |
|---|---|
| Return on Assets | -29.91% |
| Return on Invested Capital | -33.21% |
Valuation & Multiples
| P/E Ratio | -2.47 |
|---|---|
| PEG | -25.35 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.26 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Tyme Technologies Inc
Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate ...